Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (621-630 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|August 22, 2018
Multi-angle light scattering as a process analytical technology measuring real-time molecular weight for downstream process controlBhumit A Patel, Adrian Gospodarek, Michael Larkin, et al.
Mabs|August 22, 2018
High-throughput screening of antibody variants for chemical stability: identification of deamidation-resistant mutantsDanielle M DiCara, Nisana Andersen, Ruby Chan, et al.
Mabs|August 22, 2018
A minimal physiologically based pharmacokinetic model to investigate FcRn-mediated monoclonal antibody salvage: Effects of K<sub>on</sub>, K<sub>off</sub>, endosome trafficking, and animal speciesBrian M Maas, Yanguang Cao
Mabs|July 10, 2018
Comprehensive study of domain rearrangements of single-chain bispecific antibodies to determine the best combination of configurations and microbial host cellsRyutaro Asano, Yuri Kuroki, Sachiko Honma, et al.
Mabs|September 20, 2018
Comprehensive characterization of monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometryYutong Jin, Ziqing Lin, Qingge Xu, et al.
Mabs|September 11, 2018
MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicityNobuo Sekiguchi, Chiyomi Kubo, Ayako Takahashi, et al.
Mabs|November 18, 2016
Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targetingMelissa L Geddie, Neeraj Kohli, Dmitri B Kirpotin, et al.
Mabs|February 20, 2010
Accessing the human repertoire for broadly neutralizing HIV antibodiesPhilip W Hammond
Mabs|March 2, 2010
The VEGF family in cancer and antibody-based strategies for their inhibitionLaura A Sullivan, Rolf A Brekken
Mabs|January 13, 2010
Letter from the editorJanice M Reichert
Pageof 184

Showing results (621-630 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|August 22, 2018
Multi-angle light scattering as a process analytical technology measuring real-time molecular weight for downstream process controlBhumit A Patel, Adrian Gospodarek, Michael Larkin, et al.
Mabs|August 22, 2018
High-throughput screening of antibody variants for chemical stability: identification of deamidation-resistant mutantsDanielle M DiCara, Nisana Andersen, Ruby Chan, et al.
Mabs|August 22, 2018
A minimal physiologically based pharmacokinetic model to investigate FcRn-mediated monoclonal antibody salvage: Effects of K<sub>on</sub>, K<sub>off</sub>, endosome trafficking, and animal speciesBrian M Maas, Yanguang Cao
Mabs|July 10, 2018
Comprehensive study of domain rearrangements of single-chain bispecific antibodies to determine the best combination of configurations and microbial host cellsRyutaro Asano, Yuri Kuroki, Sachiko Honma, et al.
Mabs|September 20, 2018
Comprehensive characterization of monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometryYutong Jin, Ziqing Lin, Qingge Xu, et al.
Mabs|September 11, 2018
MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicityNobuo Sekiguchi, Chiyomi Kubo, Ayako Takahashi, et al.
Mabs|November 18, 2016
Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targetingMelissa L Geddie, Neeraj Kohli, Dmitri B Kirpotin, et al.
Mabs|February 20, 2010
Accessing the human repertoire for broadly neutralizing HIV antibodiesPhilip W Hammond
Mabs|March 2, 2010
The VEGF family in cancer and antibody-based strategies for their inhibitionLaura A Sullivan, Rolf A Brekken
Mabs|January 13, 2010
Letter from the editorJanice M Reichert
Pageof 184